Name: Reducing Hospital Readmissions Among Patients With Poorer Kidney Function by Population Health Learning Network
Duration: 8 min 37 s
Description: Barry Gorlitsky, MD, discusses positive treatment outcomes among patients with gout, how to lower hospital readmissions among patients with diluted blood sodium due to kidney function issues, and introduces for the first time a new lower-cost treatment option that he and his colleagues recently developed.

Barry Gorlitsky, MD, discusses positive treatment outcomes among patients with gout, how to lower hospital readmissions among patients with diluted blood sodium due to kidney function issues, and introduces for the first time a new lower-cost treatment option that he and his colleagues recently developed.

Reducing Hospital Readmissions Among Patients With Poorer Kidney Function

Sean Muldoon, MD, MPH, FCCP, SVP and chief medical officer, Hospital Division, Kindred Hospitals, identifies the major differences between long-term acute care hospitals vs traditional hospitals, and compares the varied admission lengths for patients covered by different Medicare plans, commercial insurers, and other payers.

Understanding Average Admission Length Related to Insurance Coverage

Will O’Connor, MD, chief medical information officer for TigerConnect, discusses the importance of efficient communication systems in hospitals, shortcomings of current systems, and improvements that can be implemented to make professionals’ jobs easier and provide the best possible care to patients.

Upgrading Hospital Communications Systems to Improve Patient Care and Reduce Costs

Barry Granek, LMHC, senior director at Coordinated Behavioral Care, reviews medication adherence rates among behavioral health patients, highlights how health care professionals can better ensure patients follow their treatment regimens, and discusses a digital health platform aimed at addressing adherence.

Innovations and Technology to Improve Medication Adherence Rates in Behavioral Health Patients

In an effort to bring more awareness to Clostridium difficile, Gil Melmed, MD, gastroenterologist, Cedars Sinai, Los Angeles, breaks down the typical treatment regimen for this patient population, reviews treatment guidelines, and identifies challenges linked with this condition that health systems, providers, and patients often face.

Bringing Awareness to Clostridium difficile and Reviewing the Typical Treatment Regimen

Joanne Mortimer, MD, director of women’s cancer programs at City of Hope, discusses the unique challenges of treating breast cancer, the importance of patient-centered treatment, and what payers can do to better accommodate patient needs while reducing costs.

Considering Patient Needs to Ensure Effective Treatments and Reduce Payer Costs

Jorge Cortes, MD, shares findings from the OPTIC trial on a dosing regimen of potatinib for patients with CP-CML. These data are being presented at the 2021 ASCO Annual Meeting.

Potatinib Dosing Regimen Demonstrates Improved Responses, Survival in Patients With CP-CML

Holly Pederson, MD, Cleveland Clinic, discusses siscusses ancestrally unbiased polygenic breast cancer risk assessment, presented at the 2021 ASCO Annual Meeting.

Holly Pederson, MD, Discusses Ancestrally Unbiased Polygenic Breast Cancer Risk Assessment

Dr Fakih Reviews Upfront Molecular Panel Testing in Metastatic GI Cancers

Peter Martin, MD, talks about the various treatment patterns and outcomes of US patients with MCL over the past 10 years, the findings of which were presented at the 2021 ASCO Annual Meeting.

Improvements in the Treatment of Patients With MCL Over the Past Decade

Jesus Berdeja, MD, shares findings from a phase 1 study of talquetamab therapy for relapsed/refractory MM. These data are being presented at the 2021 ASCO Annual Meeting.

Reducing Hospital Readmissions Among Patients With Poorer Kidney Function

Related tracks